Stock Market Today: Stocks Slip From Records as Gold Hits $4,000 and Shutdown Drags On
Small-Cap Stocks Post Best Quarter Since 2021 as Earnings Growth Returns
Small-cap stocks have quietly delivered their strongest quarter in four years, with the Russell 2000 index rising 12.4% in the third quarter. T
Treehouse Foods Rockets On Buyout Buzz — Inside The $3B Investindustrial Takeover Rumor!
Business & Market Movers
Breaking News
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.”
Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled “Low Glycemic Sugar Composition” developed within this platform.
Bruush Oral Care Inc. and Arrive Technology Inc. Announce Agreement and Plan of Merger
scdadmin·Dec 15, 2023
Deep Dive & Research
Healthcare & Biotech
Harrow’s MELT Acquisition Could Disrupt IV Sedation—But Is It The Hottest Pharma Small-Cap Buy?
Harrow Inc. targets Melt Pharma buyout to expand sedation portfolio with MELT-300, a sublingual non-IV sedative, aiming for U.S. launch and global partnerships while diversifying beyond ophthalmics.
Zepp Health’s Bet On Women’s Health With The Wild.AI Buyout: Strategic Leap Or Risky Play?
Phreesia’s $160 Million AccessOne Acquisition: Will This Deal Redefine Healthcare Payments?
Merck’s $10 Billion Bet On Verona: Smart Strategic Pivot Or Costly Diversion From The Keytruda Cliff?
Eli Lilly’s Obesity Pill Could Be a Game-Changer — But Here’s Why Zepbound Already Has a Giant Lead
DexCom’s Bold Type 2 Bet Could Reshape The Glucose Monitoring Market—What It Means for Investors!
Join our newsletter
Read and share new perspectives on just about any topic. Everyone’s welcome.- 01Create a free account
- 02Write your story
Tech & Energy
AMD Soars on Game-Changing Multibillion-Dollar Deal With OpenAI
Shares of Advanced Micro Devices (AMD) soared sky-high on Monday after the chipmaker revealed a game-changing partnership with OpenAI that cements its role as a key rival to Nvidia in the high-stakes AI race.
Elutia’s Game-Changing Tech Has Boston Scientific’s Full Attention— Is A Bigger Deal Coming Next?
